RNA BIOCHEMISTRY IS ONE OF THE MOST PROMISING AREAS OF MEDICINAL INNOVATION
First Health Pharmaceuticals has a leading position in the field of advanced RNA biochemistry. We aim to further develop our portfolio of highly active patented RNA Helicase inhibiting lead compounds and bring revolutionary pharmaceuticals to the market that will offer new hope for patients suffering from some of the most challenging diseases of our time.
- October 1, 2019
- breast cancer, Cancer, First Health Pharma, In the News
The Breast Cancer Awareness Month wants to raise awareness about the disease among women across the world every October. BREAST CANCER...
- September 26, 2019
- Collaborations, First Health Pharma, HIV
In its continuous efforts to improve and develop HIV treatments and cure strategies, First Health Pharmaceuticals is pleased to announce its...
- September 20, 2019
- AIDS, Events, HIV, In the News
First Health Pharmaceuticals congratulates NMAC on the 2019 USCA and Paul Kawata’s 30th anniversary as Executive Director
First Health Pharmaceuticals congratulates National Minority AIDS Council (NMAC) on a successful 2019 US Conference on AIDS (USCA). The USCA has...
- September 18, 2019
- Cancer, Events, First Health Pharma, In the News
First Heath Pharmaceuticals is thrilled to announce the participation at the European Society for Clinical Cell Analysis, ESCCA 2019, of one...
- September 3, 2019
- AIDS, Events, First Health Pharma, First Health United, HIV, In the News
First Health Pharmaceuticals will participate at the 2019 United States Conference on AIDS – USCA2019 that will be held from Sep...
- May 29, 2019
- Cancer, Collaborations, First Health Pharma
First Health Pharmaceuticals is thrilled to announce its latest collaboration on cancer research with an Oncode Institute-affiliate. Oncode is an independent...